Ed Arce
Stock Analyst at Westpark Capital
(4.84)
# 398
Out of 4,685 analysts
1071
Total ratings
48.8%
Success rate
22.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $1.22 | +145.88% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Maintained: Buy | $132 | $1.69 | +7,710.65% | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Buy | $60 | $15.24 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $75 | $5.37 | n/a | 33 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Maintained: Buy | $7.5 | $0.90 | n/a | 85 | Apr 4, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $4.69 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Maintained: Hold | n/a | $4.11 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $70 | $7.08 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Maintained: Hold | n/a | $33.91 | n/a | 30 | Mar 21, 2025 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $240 | $1.45 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.13 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $10.58 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $405 | $534.76 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $72 | $96.93 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.5 | $3.77 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $26.00 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $13.65 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $5.15 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $22 | $66.71 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $26.24 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.000001 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $16.39 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.21 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $0.099 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $33.70 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.25 | n/a | 39 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.67 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.577 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.38 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €4.06 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $26.27 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.2949 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.20 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 | $0.001 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $33.13 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.50 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $9.80 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.0001 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.0016 | n/a | 2 | Mar 19, 2013 |
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $1.22
Upside: +145.88%
MetaVia
Sep 17, 2025
Maintained: Buy
Price Target: $132
Current: $1.69
Upside: +7,710.65%
Arcturus Therapeutics Holdings
Apr 11, 2025
Maintained: Buy
Price Target: $60
Current: $15.24
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Maintained: Buy
Price Target: $75
Current: $5.37
Upside: n/a
Akebia Therapeutics
Apr 4, 2025
Maintained: Buy
Price Target: $7.5
Current: $0.90
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $4.69
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Maintained: Hold
Price Target: n/a
Current: $4.11
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Maintained: Buy
Price Target: $70
Current: $7.08
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Maintained: Hold
Price Target: n/a
Current: $33.91
Upside: n/a
Acurx Pharmaceuticals
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.45
Upside: n/a
Mar 18, 2025
Maintained: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $32
Current: $10.58
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $400 → $405
Current: $534.76
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $66 → $72
Current: $96.93
Upside: n/a
Feb 20, 2025
Maintained: Hold
Price Target: $5.5
Current: $3.77
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: $95
Current: $26.00
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $18
Current: $13.65
Upside: n/a
Jan 21, 2025
Maintained: Buy
Price Target: $5
Current: $5.15
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $18 → $22
Current: $66.71
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $48
Current: $26.24
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Sep 5, 2024
Maintained: Buy
Price Target: $13
Current: $16.39
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $1.21
Upside: n/a
Mar 26, 2024
Maintained: Buy
Price Target: $120
Current: $0.099
Upside: n/a
Jan 25, 2024
Maintained: Buy
Price Target: $25
Current: $33.70
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $4.25
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Maintained: Hold
Price Target: n/a
Current: $13.67
Upside: n/a
Nov 29, 2021
Maintained: Hold
Price Target: n/a
Current: $0.577
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $14.38
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: €12.00
Current: €4.06
Upside: n/a
Feb 7, 2020
Maintained: Buy
Price Target: $29 → $31
Current: $26.27
Upside: n/a
Nov 11, 2019
Maintained: Hold
Price Target: n/a
Current: $0.2949
Upside: n/a
Aug 12, 2019
Maintained: Buy
Price Target: $27
Current: $1.20
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $1.25
Current: $0.001
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $33.13
Upside: n/a
Nov 6, 2017
Maintained: Hold
Price Target: n/a
Current: $0.50
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Jan 26, 2015
Maintained: Buy
Price Target: $20
Current: $9.80
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.0001
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.0016
Upside: n/a